The Elehear Beyond is a behind-the-ear OTC hearing aid that earned an A grade in our lab testing, placing it among the top performers in the OTC category at #6 of 61 devices tested. Priced at $431, this 2024 release offers strong performance that helped it earn our Expert's Choice Award.
In our testing, the Beyond demonstrated strong speech clarity in quiet environments, scoring 4.3/5—a full 1.65 points above the OTC category average. Music streaming quality is another highlight, with a solid 3.8/5 score that sits 1.93 points above the category norm. Feedback handling is excellent at 4.5/5, providing stable performance without whistling during typical use.
The device does have limitations worth noting. Speech understanding in noisy environments scored 1.7/5, which is low in absolute terms even though it sits 0.50 points above the category average. Own-voice comfort measured at a mixed 2.6/5, only slightly above the category average. These results reflect the challenges that most OTC devices face in complex listening situations.
The Elehear Beyond is well-suited for budget-conscious consumers who prioritize clear speech in everyday quiet-to-moderate environments and enjoy streaming music or calls from their smartphone. It supports both iPhone and Android streaming with hands-free functionality. While it won't match prescription hearing aids in challenging noise, it delivers notable value within the OTC space, outperforming same-priced competitors like the Nuheara IQBuds Max (3.68/5) and Apple AirPods Pro 2 (3.56/5).
